Literature DB >> 8097685

Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction.

H Ikenaga1, H Suzuki, N Ishii, H Itoh, T Saruta.   

Abstract

1. To evaluate tubular damage in diabetic patients, we measured the 24 h urinary excretion of five enzymes (N-acetyl-beta-D-glucosaminidase, gamma-glutamyl transpeptidase, dipeptidyl aminopeptidase IV, alanine aminopeptidase and alkaline phosphatase) that originate in renal proximal tubular cells. 2. Studies were performed on 118 non-insulin-dependent diabetic patients, 59 non-diabetic patients with chronic renal disease and 47 normal control subjects. First, the correlation between renal function, glycaemic control and urinary enzyme excretion was investigated. Secondly, the subjects were treated by controlled diet therapy to assess the effects of better glycaemic control on urinary enzyme excretion. 3. Regardless of a diabetic or non-diabetic cause of renal dysfunction, all of the five enzymes showed abnormal urinary excretion in patients with renal insufficiency (serum creatinine concentration > 2.0 mg/dl). In diabetic patients, however, an increase in N-acetyl-beta-D-glucosaminidase excretion and a decrease in gamma-glutamyl transpeptidase excretion were noted even in those who had no signs of renal dysfunction, including microalbuminuria. Moreover, the excretion of these two enzymes had a higher degree of correlation with glycaemic control and renal function than did that of the other three enzymes. Multiple regression analysis revealed that excretion of N-acetyl-beta-D-glucosaminidase is best correlated with urinary protein (r2 = 0.35), whereas excretion of gamma-glutamyl transpeptidase is closely associated with glomerular filtration rate (r2 = 0.33). 4. In diabetic patients, diet therapy improved glycaemic control but had no effects on renal function, microalbumin excretion and beta 2-microglobulin excretion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097685     DOI: 10.1042/cs0840469

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  Biomarkers of nephrotoxic acute kidney injury.

Authors:  Michael A Ferguson; Vishal S Vaidya; Joseph V Bonventre
Journal:  Toxicology       Date:  2008-01-04       Impact factor: 4.221

2.  The use of lysosomal enzymuria in the early detection and monitoring of the progression of diabetic nephropathy.

Authors:  Donatien Gatsing; Ibrahim Hassan Garba; Godwin I Adoga
Journal:  Indian J Clin Biochem       Date:  2006-09

3.  Urinary N-acetyl beta glucosaminidase and gamma glutamyl transferase as early markers of diabetic nephropathy.

Authors:  Vivek Ambade; Parduman Sing; B L Somani; Dashrath Basanna
Journal:  Indian J Clin Biochem       Date:  2006-09

Review 4.  Biomarkers of acute kidney injury.

Authors:  Vishal S Vaidya; Michael A Ferguson; Joseph V Bonventre
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

5.  Use of the kidney injury molecule-1 as a biomarker for early detection of renal tubular dysfunction in a population chronically exposed to cadmium in the environment.

Authors:  Werawan Ruangyuttikarn; Amnart Panyamoon; Kowit Nambunmee; Ryumon Honda; Witaya Swaddiwudhipong; Muneko Nishijo
Journal:  Springerplus       Date:  2013-10-17

6.  Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.

Authors:  So Ra Kim; Yong-Ho Lee; Sang-Guk Lee; Eun Seok Kang; Bong-Soo Cha; Jeong-Ho Kim; Byung-Wan Lee
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  Biomarkers in Acute Kidney Injury.

Authors:  Jean-François Naud; Martine Leblanc
Journal:  Biomark Insights       Date:  2008-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.